Have a personal or library account? Click to login
Screening for the C9ORF72 Expansion in Greek Huntington Disease Phenocopies and Controls and Meta-analysis of Current Data Cover

Screening for the C9ORF72 Expansion in Greek Huntington Disease Phenocopies and Controls and Meta-analysis of Current Data

Tremor and Other Hyperkinetic Movements
Volume 10 (2020): Issue 0
By: Dimitrios Rikos,  Chrysoula Marogianni,  Antonios Provatas,  Thomas Bourinaris,  Marianthi Arnaoutoglou,  Pantelis Stathis,  George P. Patrinos,  Efthimios Dardiotis,  George M. Hadjigeorgiou and  Georgia Xiromerisiou  
Open Access
|Jun 2020

References

  1. 1MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell. 1993; 72(6): 971–83. DOI: 10.1016/0092-8674(93)90585-E
    Back to article
  2. 2Kremer B, Goldberg P, Andrew SE, Theilmann J, Telenius H, Zeisler J, et al. A worldwide study of the Huntington’s disease mutation: The sensitivity and specificity of measuring CAG repeats. New England Journal of Medicine. 1994; 330(20): 1401–6. DOI: 10.1056/NEJM199405193302001
    Back to article
  3. 3Wild EJ, Tabrizi SJ. Huntington’s disease phenocopy syndromes. Current opinion in neurology. 2007; 20(6): 681–7. DOI: 10.1097/WCO.0b013e3282f12074
    Back to article
  4. 4Wild EJ, Mudanohwo EE, Sweeney MG, Schneider SA, Beck J, Bhatia KP, et al. Huntington’s disease phenocopies are clinically and genetically heterogeneous. Movement Disorders. 2008; 23(5): 716–20. DOI: 10.1002/mds.21915
    Back to article
  5. 5Marogianni C, Rikos D, Provatas A, Dadouli K, Ntellas P, Tsitsi P, et al. The role of C9orf72 in neurodegenerative disorders: A systematic review, an updated meta-analysis and the creation of an online Database. Neurobiology of aging; 2019. DOI: 10.1016/j.neurobiolaging.2019.04.012
    Back to article
  6. 6DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011; 72(2): 245–56. DOI: 10.1016/j.neuron.2011.09.011
    Back to article
  7. 7Liu Y, Yu J-T, Zong Y, Zhou J, Tan L. C9ORF72 mutations in neurodegenerative diseases. Molecular neurobiology. 2014; 49(1): 386–98. DOI: 10.1007/s12035-013-8528-1
    Back to article
  8. 8Moss DJH, Poulter M, Beck J, Hehir J, Polke JM, Campbell T, et al. C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology. 2014; 82(4): 292–9. DOI: 10.1212/WNL.0000000000000061
    Back to article
  9. 9Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011; 72(2): 257–68. DOI: 10.1016/j.neuron.2011.09.010
    Back to article
  10. 10Fratta P, Poulter M, Lashley T, Rohrer JD, Polke JM, Beck J, et al. Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia. Acta neuropathologica. 2013; 126(3): 401–9. DOI: 10.1007/s00401-013-1147-0
    Back to article
  11. 11DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled clinical trials. 1986; 7(3): 177–88. DOI: 10.1016/0197-2456(86)90046-2
    Back to article
  12. 12Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the national cancer institute. 1959; 22(4): 719–48.
    Back to article
  13. 13Furuya-Kanamori L, Barendregt JJ, Doi SAR. A new improved graphical and quantitative method for detecting bias in meta-analysis. International journal of evidence-based healthcare. 2018; 16(4): 195–203. DOI: 10.1097/XEB.0000000000000141
    Back to article
  14. 14Ida CM, Butz ML, Lundquist PA, Dawson DB. C9orf72 Repeat Expansion Frequency among Patients with Huntington Disease Genetic Testing. Neuro-degenerative diseases. 2018; 18(5–6): 239–53. DOI: 10.1159/000492499
    Back to article
  15. 15Beck J, Poulter M, Hensman D, Rohrer JD, Mahoney CJ, Adamson G, et al. Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. American journal of human genetics. 2013; 92(3): 345–53. DOI: 10.1016/j.ajhg.2013.01.011
    Back to article
  16. 16Hensman Moss DJ, Poulter M, Beck J, Hehir J, Polke JM, Campbell T, et al. C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology. 2014; 82(4): 292–9. DOI: 10.1212/WNL.0000000000000061
    Back to article
  17. 17Baine FK, Peerbhai N, Krause A. A study of Huntington disease-like syndromes in black South African patients reveals a single SCA2 mutation and a unique distribution of normal alleles across five repeat loci. Journal of the neurological sciences. 2018; 390: 200–4. DOI: 10.1016/j.jns.2018.04.031
    Back to article
  18. 18Kostic VS, Dobricic V, Stankovic I, Ralic V, Stefanova E. C9orf72 expansion as a possible genetic cause of Huntington disease phenocopy syndrome. Journal of neurology. 2014; 261(10): 1917–21. DOI: 10.1007/s00415-014-7430-8
    Back to article
  19. 19Koutsis G, Karadima G, Kartanou C, Kladi A, Panas M. C9ORF72 hexanucleotide repeat expansions are a frequent cause of Huntington disease phenocopies in the Greek population. Neurobiology of aging. 2015; 36(1): 547.e13–6. DOI: 10.1016/j.neurobiolaging.2014.08.020
    Back to article
  20. 20Mariani LL, Tesson C, Charles P, Cazeneuve C, Hahn V, Youssov K, et al. Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach. JAMA neurology. 2016; 73(9): 1105–14. DOI: 10.1001/jamaneurol.2016.2215
    Back to article
  21. 21Martins J, Damasio J, Mendes A, Vila-Cha N, Alves JE, Ramos C, et al. Clinical spectrum of C9orf72 expansion in a cohort of Huntington’s disease phenocopies. Neurological sciences: Official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2018; 39(4): 741–4. DOI: 10.1007/s10072-018-3268-7
    Back to article
  22. 22Ishiura H, Tsuji S. Epidemiology and molecular mechanism of frontotemporal lobar degeneration/amyotrophic lateral sclerosis with repeat expansion mutation in C9orf72. Journal of neurogenetics. 2015; 29(2–3): 85–94. DOI: 10.3109/01677063.2015.1085980
    Back to article
  23. 23Ishiura H, Tsuji S. Epidemiology and molecular mechanism of frontotemporal lobar degeneration/amyotrophic lateral sclerosis with repeat expansion mutation in C9orf72. Journal of neurogenetics. 2015; 29(2–3): 85–94. DOI: 10.3109/01677063.2015.1085980
    Back to article
  24. 24Reilmann R, Leavitt BR, Ross CA. Diagnostic criteria for Huntington’s disease based on natural history. Movement disorders: Official journal of the Movement Disorder Society. 2014; 29(11): 1335–41. DOI: 10.1002/mds.26011
    Back to article
DOI: https://doi.org/10.5334/tohm.61 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Nov 26, 2019
Accepted on: Apr 22, 2020
Published on: Jun 12, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
C9orf72,
meta-analysis,
HD-like phenocopies,
Huntington disease

© 2020 Dimitrios Rikos, Chrysoula Marogianni, Antonios Provatas, Thomas Bourinaris, Marianthi Arnaoutoglou, Pantelis Stathis, George P. Patrinos, Efthimios Dardiotis, George M. Hadjigeorgiou, Georgia Xiromerisiou, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 10 (2020): Issue 0Next article